Latest Breaking News On - Cugen seeks fdas approval - Page 1 : comparemela.com

The submission is based on results of Bharat Biotech s Phase 2/3 paediatric clinical trial involving 526 children between 2-18 years of age

United statesShankar musunuriWorld health organizationDrug administrationOcugen incBharat biotechEmergency use authorizationChief executive officerEmergency use listingWorld healthBharat biotechEmergency use authorization euaCugen seeks fdas approval